{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:18:55Z","timestamp":1789985935375,"version":"4.0.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,12,4]],"date-time":"2017-12-04T00:00:00Z","timestamp":1512345600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s11064-017-2445-z","type":"journal-article","created":{"date-parts":[[2017,12,4]],"date-time":"2017-12-04T04:36:52Z","timestamp":1512362212000},"page":"488-499","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Protective Effects of Fisetin Against 6-OHDA-Induced Apoptosis by Activation of PI3K-Akt Signaling in Human Neuroblastoma SH-SY5Y Cells"],"prefix":"10.1007","volume":"43","author":[{"given":"Ryoko","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takumi","family":"Kurose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Morishige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2506-0769","authenticated-orcid":false,"given":"Ko","family":"Fujimori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,4]]},"reference":[{"key":"2445_CR1","doi-asserted-by":"crossref","first-page":"2525967","DOI":"10.1155\/2017\/2525967","volume":"2017","author":"Z Liu","year":"2017","unstructured":"Liu Z, Zhou T, Ziegler AC, Dimitrion P, Zuo L (2017) Oxidative stress in neurodegenerative diseases: from molecular mechanisms to clinical applications. Oxid Med Cell Longev 2017:2525967","journal-title":"Oxid Med Cell Longev"},{"key":"2445_CR2","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nrg1831","volume":"7","author":"MJ Farrer","year":"2006","unstructured":"Farrer MJ (2006) Genetics of Parkinson disease: paradigm shifts and future prospects. Nat Rev Genet 7:306\u2013318","journal-title":"Nat Rev Genet"},{"key":"2445_CR3","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1177\/0891988710383572","volume":"23","author":"LM Bekris","year":"2010","unstructured":"Bekris LM, Mata IF, Zabetian CP (2010) The genetics of Parkinson disease. J Geriatr Psychiatry Neurol 23:228\u2013242","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"2445_CR4","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3233\/JPD-130230","volume":"3","author":"V Dias","year":"2013","unstructured":"Dias V, Junn E, Mouradian MM (2013) The role of oxidative stress in Parkinson\u2019s disease. J Parkinsons Dis 3:461\u2013491","journal-title":"J Parkinsons Dis"},{"key":"2445_CR5","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.neuint.2005.11.008","volume":"48","author":"V Lehmensiek","year":"2006","unstructured":"Lehmensiek V, Tan EM, Liebau S, Lenk T, Zettlmeisl H, Schwarz J, Storch A (2006) Dopamine transporter-mediated cytotoxicity of 6-hydroxydopamine in vitro depends on expression of mutant alpha-synucleins related to Parkinson\u2019s disease. Neurochem Int 48:329\u2013340","journal-title":"Neurochem Int"},{"key":"2445_CR6","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1471-2202-9-75","volume":"9","author":"WJ Yuan","year":"2008","unstructured":"Yuan WJ, Yasuhara T, Shingo T, Muraoka K, Agari T, Kameda M, Uozumi T, Tajiri N, Morimoto T, Jing M, Baba T, Wang F, Leung H, Matsui T, Miyoshi Y, Date I (2008) Neuroprotective effects of edaravone-administration on 6-OHDA-treated dopaminergic neurons. BMC Neurosci 9:75","journal-title":"BMC Neurosci"},{"key":"2445_CR7","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.neures.2008.09.001","volume":"62","author":"J Henning","year":"2008","unstructured":"Henning J, Strauss U, Wree A, Gimsa J, Rolfs A, Benecke R, Gimsa U (2008) Differential astroglial activation in 6-hydroxydopamine models of Parkinson\u2019s disease. Neurosci Res 62:246\u2013253","journal-title":"Neurosci Res"},{"issue":"Suppl 3","key":"2445_CR8","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.3233\/JAD-132738","volume":"42","author":"E Radi","year":"2014","unstructured":"Radi E, Formichi P, Battisti C, Federico A (2014) Apoptosis and oxidative stress in neurodegenerative diseases. J Alzheimers Dis 42(Suppl 3):S125\u2013S152","journal-title":"J Alzheimers Dis"},{"key":"2445_CR9","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2174\/1570159X13666151030102718","volume":"14","author":"R Filograna","year":"2016","unstructured":"Filograna R, Beltramini M, Bubacco L, Bisaglia M (2016) Anti-oxidants in parkinson\u2019s disease therapy: a critical point of view. Curr Neuropharmacol 14:260\u2013271","journal-title":"Curr Neuropharmacol"},{"key":"2445_CR10","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1001\/jama.2014.3654","volume":"311","author":"BS Connolly","year":"2014","unstructured":"Connolly BS, Lang AE (2014) Pharmacological treatment of Parkinson disease: a review. JAMA 311:1670\u20131683","journal-title":"JAMA"},{"key":"2445_CR11","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1002\/mds.26819","volume":"31","author":"KC Hughes","year":"2016","unstructured":"Hughes KC, Gao X, Kim IY, Rimm EB, Wang M, Weisskopf MG, Schwarzschild MA, Ascherio A (2016) Intake of antioxidant vitamins and risk of Parkinson\u2019s disease. Mov Disord 31:1909\u20131914","journal-title":"Mov Disord"},{"key":"2445_CR12","first-page":"4180","volume":"23","author":"NA Mazo","year":"2017","unstructured":"Mazo NA, Echeverria V, Cabezas R, Avila-Rodriguez M, Aliev G, Leszek J, Barreto GE (2017) Medicinal plants as protective strategies against Parkinson\u2019s disease. Curr Pharm Des 23:4180\u20134188","journal-title":"Curr Pharm Des"},{"key":"2445_CR13","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0024-3205(99)00120-4","volume":"65","author":"G Carlo Di","year":"1999","unstructured":"Di Carlo G, Mascolo N, Izzo AA, Capasso F (1999) Flavonoids: old and new aspects of a class of natural therapeutic drugs. Life Sci 65:337\u2013353","journal-title":"Life Sci"},{"key":"2445_CR14","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3390\/ijms17040569","volume":"17","author":"M Kawser Hossain","year":"2016","unstructured":"Kawser Hossain M, Abdal Dayem A, Han J, Yin Y, Kim K, Kumar Saha S, Yang GM, Choi HY, Cho SG (2016) Molecular mechanisms of the anti-obesity and anti-diabetic properties of flavonoids. Int J Mol Sci 17:569","journal-title":"Int J Mol Sci"},{"key":"2445_CR15","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.intimp.2011.03.012","volume":"11","author":"M Funakoshi-Tago","year":"2011","unstructured":"Funakoshi-Tago M, Nakamura K, Tago K, Mashino T, Kasahara T (2011) Anti-inflammatory activity of structurally related flavonoids, apigenin, luteolin and fisetin. Int Immunopharmacol 11:1150\u20131159","journal-title":"Int Immunopharmacol"},{"key":"2445_CR16","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0163-7258(01)00137-1","volume":"90","author":"DF Birt","year":"2001","unstructured":"Birt DF, Hendrich S, Wang W (2001) Dietary agents in cancer prevention: flavonoids and isoflavonoids. Pharmacol Ther 90:157\u2013177","journal-title":"Pharmacol Ther"},{"key":"2445_CR17","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1093\/ajcn\/74.4.418","volume":"74","author":"RJ Nijveldt","year":"2001","unstructured":"Nijveldt RJ, van Nood E, van Hoorn DE, Boelens PG, van Norren K, van Leeuwen PA (2001) Flavonoids: a review of probable mechanisms of action and potential applications. Am J Clin Nutr 74:418\u2013425","journal-title":"Am J Clin Nutr"},{"key":"2445_CR18","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1158\/1535-7163.MCT-05-0370","volume":"5","author":"S Shukla","year":"2006","unstructured":"Shukla S, Gupta S (2006) Molecular targets for apigenin-induced cell cycle arrest and apoptosis in prostate cancer cell xenograft. Mol Cancer Ther 5:843\u2013852","journal-title":"Mol Cancer Ther"},{"key":"2445_CR19","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1111\/j.1471-4159.2004.02563.x","volume":"90","author":"Y Sagara","year":"2004","unstructured":"Sagara Y, Vanhnasy J, Maher P (2004) Induction of PC12 cell differentiation by flavonoids is dependent upon extracellular signal-regulated kinase activation. J Neurochem 90:1144\u20131155","journal-title":"J Neurochem"},{"issue":"4","key":"2445_CR20","doi-asserted-by":"crossref","first-page":"852","DOI":"10.3390\/ijms18040852","volume":"18","author":"JH Yen","year":"2017","unstructured":"Yen JH, Wu PS, Chen SF, Wu MJ (2017) Fisetin protects PC12 cells from tunicamycin-mediated cell death via reactive oxygen species scavenging and modulation of Nrf2-driven gene expression, SIRT1 and MAPK signaling in PC12 cells. Int J Mol Sci 18(4):852","journal-title":"Int J Mol Sci"},{"key":"2445_CR21","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.intimp.2007.12.012","volume":"8","author":"LT Zheng","year":"2008","unstructured":"Zheng LT, Ock J, Kwon BM, Suk K (2008) Suppressive effects of flavonoid fisetin on lipopolysaccharide-induced microglial activation and neurotoxicity. Int Immunopharmacol 8:484\u2013494","journal-title":"Int Immunopharmacol"},{"key":"2445_CR22","doi-asserted-by":"crossref","first-page":"16568","DOI":"10.1073\/pnas.0607822103","volume":"103","author":"P Maher","year":"2006","unstructured":"Maher P, Akaishi T, Abe K (2006) Flavonoid fisetin promotes ERK-dependent long-term potentiation and enhances memory. Proc Natl Acad Sci USA 103:16568\u201316573","journal-title":"Proc Natl Acad Sci USA"},{"key":"2445_CR23","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jnutbio.2015.07.017","volume":"26","author":"D Prakash","year":"2015","unstructured":"Prakash D, Sudhandiran G (2015) Dietary flavonoid fisetin regulates aluminium chloride-induced neuronal apoptosis in cortex and hippocampus of mice brain. J Nutr Biochem 26:1527\u20131539","journal-title":"J Nutr Biochem"},{"key":"2445_CR24","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3233\/JPD-012110","volume":"2","author":"MY Patel","year":"2012","unstructured":"Patel MY, Panchal HV, Ghribi O, Benzeroual KE (2012) The neuroprotective effect of fisetin in the MPTP model of Parkinson\u2019s disease. J Parkinsons Dis 2:287\u2013302","journal-title":"J Parkinsons Dis"},{"key":"2445_CR25","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1080\/10715760500233113","volume":"39","author":"V Zbarsky","year":"2005","unstructured":"Zbarsky V, Datla KP, Parkar S, Rai DK, Aruoma OI, Dexter DT (2005) Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson\u2019s disease. Free Radic Res 39:1119\u20131125","journal-title":"Free Radic Res"},{"key":"2445_CR26","doi-asserted-by":"crossref","first-page":"e0163640","DOI":"10.1371\/journal.pone.0163640","volume":"11","author":"Y Nakao","year":"2016","unstructured":"Nakao Y, Yoshihara H, Fujimori K (2016) Suppression of very early stage of adipogenesis by baicalein, a plant-derived flavonoid through reduced Akt-C\/EBP\u03b1-GLUT4 signaling-mediated glucose uptake in 3T3-L1 adipocytes. PLoS ONE 11:e0163640","journal-title":"PLoS ONE"},{"key":"2445_CR27","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1158\/2159-8290.CD-13-0611","volume":"4","author":"M Will","year":"2014","unstructured":"Will M, Qin AC, Toy W, Yao Z, Rodrik-Outmezguine V, Schneider C, Huang X, Monian P, Jiang X, de Stanchina E, Baselga J, Liu N, Chandarlapaty S, Rosen N (2014) Rapid induction of apoptosis by PI3K inhibitors is dependent upon their transient inhibition of RAS-ERK signaling. Cancer Discov 4:334\u2013347","journal-title":"Cancer Discov"},{"key":"2445_CR28","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.expneurol.2017.06.017","volume":"298","author":"GF Crotty","year":"2017","unstructured":"Crotty GF, Ascherio A, Schwarzschild MA (2017) Targeting urate to reduce oxidative stress in Parkinson disease. Exp Neurol 298:210\u2013224","journal-title":"Exp Neurol"},{"key":"2445_CR29","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.3390\/molecules16021471","volume":"16","author":"AK Jager","year":"2011","unstructured":"Jager AK, Saaby L (2011) Flavonoids and the CNS. Molecules 16:1471\u20131485","journal-title":"Molecules"},{"key":"2445_CR30","doi-asserted-by":"crossref","first-page":"171756","DOI":"10.1155\/2015\/171756","volume":"2015","author":"TC Diniz","year":"2015","unstructured":"Diniz TC, Silva JC, de Lima-Saraiva SR, Ribeiro FP, Pacheco AG, de Freitas RM, Quintans-Junior LJ, Quintans Jde S, Mendes RL, Almeida JR (2015) The role of flavonoids on oxidative stress in epilepsy. Oxid Med Cell Longev 2015:171756","journal-title":"Oxid Med Cell Longev"},{"key":"2445_CR31","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/ptr.5834","volume":"31","author":"ZY Wang","year":"2017","unstructured":"Wang ZY, Liu JY, Yang CB, Malampati S, Huang YY, Li MX, Li M, Song JX (2017) Neuroprotective natural products for the treatment of parkinson\u2019s disease by targeting the autophagy-lysosome pathway: a systematic review. Phytother Res 31:1119\u20131127","journal-title":"Phytother Res"},{"key":"2445_CR32","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1038\/2121273a0","volume":"212","author":"M Gabor","year":"1966","unstructured":"Gabor M, Eperjessy E (1966) Antibacterial effect of fisetin and fisetinidin. Nature 212:1273","journal-title":"Nature"},{"key":"2445_CR33","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.bcp.2012.07.012","volume":"84","author":"VM Adhami","year":"2012","unstructured":"Adhami VM, Syed DN, Khan N, Mukhtar H (2012) Dietary flavonoid fisetin: a novel dual inhibitor of PI3K\/Akt and mTOR for prostate cancer management. Biochem Pharmacol 84:1277\u20131281","journal-title":"Biochem Pharmacol"},{"key":"2445_CR34","doi-asserted-by":"crossref","first-page":"4979","DOI":"10.1021\/acs.jafc.5b00821","volume":"63","author":"M Watanabe","year":"2015","unstructured":"Watanabe M, Hisatake M, Fujimori K (2015) Fisetin suppresses lipid accumulation in mouse adipocytic 3T3-L1 cells by repressing GLUT4-mediated glucose uptake through inhibition of mTOR-C\/EBP\u03b1 signaling. J Agric Food Chem 63:4979\u20134987","journal-title":"J Agric Food Chem"},{"key":"2445_CR35","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glx104","author":"A Currais","year":"2017","unstructured":"Currais A, Farrokhi C, Dargusch R, Armando A, Quehenberger O, Schubert D, Maher P (2017) Fisetin reduces the impact of aging on behavior and physiology in the rapidly aging SAMP8 mouse. J Gerontol A Biol Sci Med Sci. https:\/\/doi.org\/10.1093\/gerona\/glx104","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2445_CR36","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/acel.12185","volume":"13","author":"A Currais","year":"2014","unstructured":"Currais A, Prior M, Dargusch R, Armando A, Ehren J, Schubert D, Quehenberger O, Maher P (2014) Modulation of p25 and inflammatory pathways by fisetin maintains cognitive function in Alzheimer\u2019s disease transgenic mice. Aging Cell 13:379\u2013390","journal-title":"Aging Cell"},{"key":"2445_CR37","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1002\/ijc.26178","volume":"130","author":"N Khan","year":"2012","unstructured":"Khan N, Afaq F, Khusro FH, Mustafa Adhami V, Suh Y, Mukhtar H (2012) Dual inhibition of phosphatidylinositol 3-kinase\/Akt and mammalian target of rapamycin signaling in human nonsmall cell lung cancer cells by a dietary flavonoid fisetin. Int J Cancer 130:1695\u20131705","journal-title":"Int J Cancer"},{"key":"2445_CR38","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0005-2728(98)00109-1","volume":"1366","author":"J Cai","year":"1998","unstructured":"Cai J, Yang J, Jones DP (1998) Mitochondrial control of apoptosis: the role of cytochrome c. Biochim Biophys Acta 1366:139\u2013149","journal-title":"Biochim Biophys Acta"},{"key":"2445_CR39","doi-asserted-by":"crossref","first-page":"E209","DOI":"10.1038\/70237","volume":"1","author":"MG Vander Heiden","year":"1999","unstructured":"Vander Heiden MG, Thompson CB (1999) Bcl-2 proteins: regulators of apoptosis or of mitochondrial homeostasis? Nat Cell Biol 1:E209\u2013E216","journal-title":"Nat Cell Biol"},{"key":"2445_CR40","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0304-3940(97)00837-9","volume":"238","author":"A Tortosa","year":"1997","unstructured":"Tortosa A, Lopez E, Ferrer I (1997) Bcl-2 and Bax proteins in lewy bodies from patients with Parkinson\u2019s disease and diffuse lewy body disease. Neurosci Lett 238:78\u201380","journal-title":"Neurosci Lett"},{"key":"2445_CR41","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1046\/j.0022-202x.2001.01409.x","volume":"117","author":"M Raisova","year":"2001","unstructured":"Raisova M, Hossini AM, Eberle J, Riebeling C, Wieder T, Sturm I, Daniel PT, Orfanos CE, Geilen CC (2001) The Bax\/Bcl-2 ratio determines the susceptibility of human melanoma cells to CD95\/Fas-mediated apoptosis. J Invest Dermatol 117:333\u2013340","journal-title":"J Invest Dermatol"},{"key":"2445_CR42","first-page":"287","volume":"6","author":"PY Chen","year":"2015","unstructured":"Chen PY, Ho YR, Wu MJ, Huang SP, Chen PK, Tai MH, Ho CT, Yen JH (2015) Cytoprotective effects of fisetin against hypoxia-induced cell death in PC12 cells. Food Funct 6:287\u2013296","journal-title":"Food Funct"},{"key":"2445_CR43","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.cellsig.2006.01.011","volume":"18","author":"AM Martelli","year":"2006","unstructured":"Martelli AM, Faenza I, Billi AM, Manzoli L, Evangelisti C, Fala F, Cocco L (2006) Intranuclear 3\u2032-phosphoinositide metabolism and Akt signaling: new mechanisms for tumorigenesis and protection against apoptosis? Cell Signal 18:1101\u20131107","journal-title":"Cell Signal"},{"key":"2445_CR44","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1177\/030089160409000102","volume":"90","author":"S Brader","year":"2004","unstructured":"Brader S, Eccles SA (2004) Phosphoinositide 3-kinase signalling pathways in tumor progression, invasion and angiogenesis. Tumori 90:2\u20138","journal-title":"Tumori"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-017-2445-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-017-2445-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-017-2445-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T00:13:16Z","timestamp":1751069596000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-017-2445-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,4]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["2445"],"URL":"https:\/\/doi.org\/10.1007\/s11064-017-2445-z","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,4]]}}}